Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation

MLA

Pin-Yi Wang, et al. “Aurora A Kinase Inhibition Enhances Oncolytic Herpes Virotherapy through Cytotoxic Synergy and Innate Cellular Immune Modulation.” Oncotarget, vol. 8, Feb. 2017, pp. 17412–27. EBSCOhost, https://doi.org/10.18632/oncotarget.14885.

APA

Pin-Yi Wang, Katherine E. Chaney, Brian Hutzen, Meghan Franczek, Timothy P. Cripe, Joe Conner, Brooke Nartker, Chun-Yu Chen, Tilat A. Rizvi, Les Sprague, Ami V. Patel, Nancy Ratner, Jeffrey Ecsedy, Keri A. Streby, & Mark A. Currier. (2017). Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation. Oncotarget, 8, 17412–17427. https://doi.org/10.18632/oncotarget.14885

Chicago

Pin-Yi Wang, Katherine E. Chaney, Brian Hutzen, Meghan Franczek, Timothy P. Cripe, Joe Conner, Brooke Nartker, et al. 2017. “Aurora A Kinase Inhibition Enhances Oncolytic Herpes Virotherapy through Cytotoxic Synergy and Innate Cellular Immune Modulation.” Oncotarget 8 (February): 17412–27. doi:10.18632/oncotarget.14885.